Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma
肿瘤异质性是体细胞NF1突变型胶质母细胞瘤临床结果和MEK抑制剂反应的基础
期刊:JCI Insight
影响因子:6.1
doi:10.1172/jci.insight.192658
Pan, Sixuan; Mirchia, Kanish; Payne, Emily; Liu, S John; Al-Adli, Nadeem; Peeran, Zain; Shukla, Poojan; Young, Jacob S; Gupta, Rohit; Wu, Jasper; Pak, Joanna; Ozawa, Tomoko; Na, Brian; Reddy, Alyssa T; Braunstein, Steve E; Phillips, Joanna J; Chang, Susan; Solomon, David A; Perry, Arie; Raleigh, David R; Berger, Mitchel S; Abate, Adam R; Vasudevan, Harish N